Try our beta test site
44 studies found for:    eisai alzheimer's
Show Display Options
Rank Status Study
1 Completed EARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD)
Condition: Alzheimer's Disease
Intervention: Drug: Aricept
2 Completed
Has Results
Comparison of 23 mg Donepezil Sustained Release (SR) to 10 mg Donepezil Immediate Release (IR) in Patients With Moderate to Severe Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Aricept (donepezil SR 23 mg);   Drug: Aricept (donepezil IR 10 mg)
3 Completed
Has Results
Open-Label Extension Study of 23 mg Donepezil SR in Patients With Moderate to Severe Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: 23 mg SR in Study 326;   Drug: 10 mg IR in Study 326
4 Completed A Randomized, Double-blind, Placebo-controlled, Combined Single Ascending Dose and Multiple Ascending Dose Study
Condition: Alzheimer's Disease
Interventions: Drug: Active Comparator: A;   Drug: Placebo Comparator B;   Drug: Active Comparator B;   Drug: Placebo Comparator A
5 Completed
Has Results
The Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon Gene Polymorphisms to Donepezil in Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Donepezil
6 Completed The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility
Condition: Mild to Severe Alzheimer's Disease
Intervention: Drug: Donepezil HCl
7 Active, not recruiting A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: BAN2401 2.5 mg/kg;   Drug: BAN2401 5.0 mg/kg;   Drug: BAN2401 10 mg/kg
8 Recruiting A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: elenbecestat (E2609);   Drug: Placebo
9 Recruiting A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Condition: Alzheimer's Disease
Interventions: Drug: elenbecestat (E2609);   Drug: Placebo
10 Completed Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Clinical Safety and Effectiveness in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: donepezil hydrochloride
11 Completed Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's Disease
Conditions: Alzheimer's Disease;   Dementia
Intervention: Drug: Donepezil hydrochloride
12 Completed A 24-weeks, Multi-center, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Donepezil Hydrochloride in Chinese Subjects With Severe Alzheimer's Disease
Condition: Alzheimer's Type Dementia
Interventions: Drug: E2020;   Drug: Placebo
13 Completed Alzheimer's Disease Long-term Follow-up Study (ALF Study)
Condition: Alzheimer's Disease
Intervention: Drug: Donepezil Hydrochloride
14 Completed Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Factors That Affect Aricept Medication Persistence Rate and the Safety and Efficacy in Patients With Alzheimer's Disease in Clinical Practice
Condition: Alzheimer's Disease
Intervention: Drug: Donepezil Hydrochloride
15 Recruiting Study of Lemborexant for Irregular Sleep-Wake Rhythm Disorder and Mild to Moderate Alzheimer's Disease Dementia
Condition: Irregular Sleep-Wake Rhythm Disorder
Interventions: Drug: Lemborexant 2.5 mg;   Drug: Lemborexant 5 mg;   Drug: Lemborexant 10 mg;   Drug: Lemborexant 15 mg;   Drug: Lemborexant-matched placebo
16 Completed Post-marketing Surveillance of Long-term Administration of Donepezil Hydrochloride -Investigation of the Clinical Condition and Safety in Patients With Alzheimer's Disease-
Condition: Alzheimer's Disease
Intervention: Drug: donepezil hydrochloride
17 Completed
Has Results
A Study Versus E2020 10mg Followed by an Open-label Extension Phase to Explore the Safety of E2020 SR 23 mg in Japanese Subjects With Severe Alzheimer's Type Dementia
Condition: Alzheimer's Type Dementia
Intervention: Drug: E2020
18 Completed Compare the Efficacy and Safety of Donepezil Hydrochloride 23 mg Treatment With Continuation of Donepezil Hydrochloride 10 mg Treatment in Japanese Subjects With Severe Alzheimer's Disease
Condition: Alzheimer's Type Dementia
Intervention: Drug: E2020
19 Completed Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD)
Conditions: Dementia;   Alzheimer's Disease
Intervention: Drug: Rasagiline
20 Completed Hippocampus Study: Comparative Effect of Donepezil 10mg/d and Placebo on Clinical and Radiological Markers
Condition: Alzheimer's Disease
Interventions: Drug: Experimental 1;   Drug: Placebo Comparator

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.